首页 | 本学科首页   官方微博 | 高级检索  
     

淋巴结阴性乳腺癌p21~(waf1)、c-erbB-2和p53蛋白表达及其临床意义
引用本文:杜巍,曾灿光,戎铁华,侯景辉. 淋巴结阴性乳腺癌p21~(waf1)、c-erbB-2和p53蛋白表达及其临床意义[J]. 癌症, 2001, 0(6)
作者姓名:杜巍  曾灿光  戎铁华  侯景辉
作者单位:衡阳医学院第二附属医院胸外科!湖南衡阳421001,中山医科大学肿瘤防治中心胸科!广东 广州510060,中山医科大学肿瘤防治中心胸科!广东 广州510060,中山医科大学肿瘤防治中心胸科病理科!广东 广州510060
摘    要:目的:探讨腋淋巴结阴性乳腺癌组织中p21waf1、c-erbB-2和p53基因蛋白表达及其与临床病理参数和预后的关系。方法:应用免疫组化LSAB方法检测121例腋淋巴结阴性乳腺癌石蜡切片中p21waf1、c-erbB-2和p53蛋白的表达情况;同时应用Kaplan-Meier法及多变量Cox比例风险模型,分析3种蛋白表达与预后的关系。结果:(1)p21waf1蛋白表达率为 48. 8%,与病理组织学分级、ER状态有关; p53蛋白表达率为 36. 4%, c-erbB-2蛋白表达率为 26. 4%,与组织学分级有关;(2)p21waf1阳性表达与 p53表达呈负相关( P< 0. 05);(3)p21waf1阳性组患者无瘤生存率高于阴性组(P<0.05);c-erbB-2阳性组患者无瘤生存率明显低于阴性组(P<0 01);Cox模型分析显示仅有c-erbB-2表达对预后有显著影响。结论:乳腺癌组织p21waf1、c-erbB-2表达与病理组织学分级有相关性;p21waf1表达依赖于p53途径刺激; p21waf1、、c-erbB-2表达与腋淋巴结阴性乳腺癌预后有关,且c-erbB-2表达是一个独立的预后指标。

关 键 词:乳腺肿瘤  p21waf1  c-erbB-2  p53  预后

Expression of p21~(waf1), c-erbB-2, and p53 Genes in Node-Negative Breast Carcinoma and Their Clinical Significance
DU Wei,ZENG Can-guang,RONG Tie-hua,HOU Jing-hui. Expression of p21~(waf1), c-erbB-2, and p53 Genes in Node-Negative Breast Carcinoma and Their Clinical Significance[J]. Chinese journal of cancer, 2001, 0(6)
Authors:DU Wei  ZENG Can-guang  RONG Tie-hua  HOU Jing-hui
Abstract:Objective: The aim of this study was to determine the expression of p21waf1, c-erbB-2, and p53 in node-negative breast cancer in relation to the clinicopathological parameters and prognosis. Methods: Expression of p21waf1, c-erbB-2 and p53 in 121 patients were determined by LSAB immunohistochemical method, and Kaplan-Meter method and Cox proportional hazard model were used to analyze the relationship of their expressions with prognosis. Results: (1) The expression rate of p21waf1 was 48. 8% , and was in connection with histological grade and ER-positive. (2 ) The expression rate of p53 and c-erbB-2 was 36. 4% and 26. 4% respectively. C-erbB-2 positive expression was associated with histological grade. (3 ) the expression of p21waf1 was inversely correlated with that of p53 protein (P < 0. 05 ). (4) the results of survival analysis with Kaplan-Meter method showed that better disease-free survival(DFS) in the patients with p21waf1 expression than those without, the negative c-erbB-2 expression exhibited a significantly better prognosis than positive c-erbB-2 expression (P < 0. 01 ). Conclusions: There was a significant correlation between the expression of p21waf1, c-erbB-2, and tumor grade; a p53-indenpent pathway can mainly induce the expression of p21waf1; p21waf1 expression was a good prognostic marker for the patients with node-negative breast cancer; c-erbB- 2 positive expression was an independent prognostic marker.
Keywords:Breast carcinoma  p21 waf1  c-erbB-2  p53  Prognosis
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号